Novartis AG
Licofligozin for the treatment of non-alcoholic steatohepatitis
Last updated:
Abstract:
The disclosure concerns the use of LIK066 in the treatment, prevention or delay of non-alcoholic steatohepatitis.
Status:
Grant
Type:
Utility
Filling date:
20 Jun 2018
Issue date:
23 Nov 2021